Published in Infect Immun on August 11, 2008
The myriad roles of cyclic AMP in microbial pathogens: from signal to sword. Nat Rev Microbiol (2011) 1.58
Localization and developmental regulation of a dispersed gene family 1 protein in Trypanosoma cruzi. Infect Immun (2009) 0.89
Defining the role of a FYVE domain in the localization and activity of a cAMP phosphodiesterase implicated in osmoregulation in Trypanosoma cruzi. Mol Microbiol (2010) 0.86
Identification of Toxoplasma gondii cAMP dependent protein kinase and its role in the tachyzoite growth. PLoS One (2011) 0.83
The role of acidocalcisomes in the stress response of Trypanosoma cruzi. Adv Parasitol (2011) 0.83
Molecular cloning and characterization of mitogen-activated protein kinase 2 in Trypanosoma cruzi. Cell Cycle (2010) 0.83
Protein kinase A catalytic subunit interacts and phosphorylates members of trans-sialidase super-family in Trypanosoma cruzi. Microbes Infect (2010) 0.83
Quantitative proteomic and phosphoproteomic analysis of Trypanosoma cruzi amastigogenesis. Mol Cell Proteomics (2014) 0.81
The ever unfolding story of cAMP signaling in trypanosomatids: vive la difference! Front Pharmacol (2015) 0.77
Golgi UDP-GlcNAc:polypeptide O-α-N-Acetyl-d-glucosaminyltransferase 2 (TcOGNT2) regulates trypomastigote production and function in Trypanosoma cruzi. Eukaryot Cell (2014) 0.77
A Multilayer Network Approach for Guiding Drug Repositioning in Neglected Diseases. PLoS Negl Trop Dis (2016) 0.76
A method for rapid regulation of protein expression in Trypanosoma cruzi. Int J Parasitol (2011) 0.76
Conservation of protein kinase a catalytic subunit sequences in the schistosome pathogens of humans. Exp Parasitol (2010) 0.75
cAMP signalling in trypanosomatids: role in pathogenesis and as a drug target. Trends Parasitol (2015) 0.75
Three different genes in S. cerevisiae encode the catalytic subunits of the cAMP-dependent protein kinase. Cell (1987) 6.35
cAMP-dependent protein kinase: framework for a diverse family of regulatory enzymes. Annu Rev Biochem (1990) 5.02
Novel sensing mechanisms and targets for the cAMP-protein kinase A pathway in the yeast Saccharomyces cerevisiae. Mol Microbiol (1999) 3.98
The three yeast A kinases have specific signaling functions in pseudohyphal growth. Proc Natl Acad Sci U S A (1998) 3.33
An evolutionary proteomics approach identifies substrates of the cAMP-dependent protein kinase. Proc Natl Acad Sci U S A (2005) 2.60
PKA: a portrait of protein kinase dynamics. Biochim Biophys Acta (2004) 2.43
Differentiation of African trypanosomes is controlled by a density sensing mechanism which signals cell cycle arrest via the cAMP pathway. J Cell Sci (1997) 2.39
RAS genes in Saccharomyces cerevisiae: signal transduction in search of a pathway. Trends Genet (1991) 2.29
cAMP-Specific phosphodiesterase-4 enzymes in the cardiovascular system: a molecular toolbox for generating compartmentalized cAMP signaling. Circ Res (2007) 2.21
Trypanosoma cruzi in Los Angeles and Miami blood donors: impact of evolving donor demographics on seroprevalence and implications for transfusion transmission. Transfusion (2002) 1.95
The phosphoinositide (PI) 3-kinase family. J Cell Sci (2003) 1.94
Mutations of the adenylyl cyclase gene that block RAS function in Saccharomyces cerevisiae. Science (1990) 1.91
Stationary phase in yeast. Curr Opin Microbiol (2002) 1.78
Leucine-rich repeats and carboxyl terminus are required for interaction of yeast adenylate cyclase with RAS proteins. Proc Natl Acad Sci U S A (1990) 1.63
In silico prediction of the glycosomal enzymes of Leishmania major and trypanosomes. Mol Biochem Parasitol (2006) 1.36
Glycosomes: parasites and the divergence of peroxisomal purpose. Mol Microbiol (2004) 1.29
A functional aquaporin co-localizes with the vacuolar proton pyrophosphatase to acidocalcisomes and the contractile vacuole complex of Trypanosoma cruzi. J Biol Chem (2004) 1.26
Acidocalcisomes and the contractile vacuole complex are involved in osmoregulation in Trypanosoma cruzi. J Biol Chem (2004) 1.26
Role of PKA in the timing of developmental events in Dictyostelium cells. Microbiol Mol Biol Rev (1998) 1.20
Cyclic AMP and adenylate cyclase activators stimulate Trypanosoma cruzi differentiation. Exp Parasitol (1988) 1.17
Pathology of patients with Chagas' disease and acquired immunodeficiency syndrome. Am J Trop Med Hyg (1994) 1.10
Comparison of adenylate cyclase and cAMP-dependent protein kinase in gametocytogenic and nongametocytogenic clones of Plasmodium falciparum. J Parasitol (1991) 1.00
Reactivation of Chagas' disease in a human immunodeficiency virus-infected patient leading to severe heart disease with a late positive direct microscopic examination of the blood. Am J Trop Med Hyg (1998) 0.97
A contractile vacuole complex is involved in osmoregulation in Trypanosoma cruzi. Exp Parasitol (2007) 0.94
Cyclic AMP signaling in trypanosomatids. Parasitol Today (2000) 0.94
Chagasic meningoencephalitis in a patient with acquired immunodeficiency syndrome: diagnosis, follow-up, and genetic characterization of Trypanosoma cruzi. Clin Infect Dis (2001) 0.94
Simultaneous occurrence of acute myocarditis and reactivated Chagas' disease in a patient with AIDS. Clin Infect Dis (1995) 0.93
Molecular cloning and characterization of the protein kinase A regulatory subunit of Trypanosoma cruzi. Mol Biochem Parasitol (2006) 0.89
TcrPDEA1, a cAMP-specific phosphodiesterase with atypical pharmacological properties from Trypanosoma cruzi. Mol Biochem Parasitol (2006) 0.85
Molecular cloning and expression of the catalytic subunit of protein kinase A from Trypanosoma cruzi. Int J Parasitol (2002) 0.84
Infections by protozoa in immunocompromised hosts. Mem Inst Oswaldo Cruz (2000) 0.84
Molecular and biochemical characterization of novel glucokinases from Trypanosoma cruzi and Leishmania spp. Mol Biochem Parasitol (2007) 0.80
Microsporidiosis: current status. Curr Opin Infect Dis (2006) 2.81
Toxoplasma gondii: the model apicomplexan. Int J Parasitol (2004) 2.10
Blastocystis: to treat or not to treat... Clin Infect Dis (2011) 2.01
Z-score reference ranges for normal fetal heart sizes throughout pregnancy derived from fetal echocardiography. Prenat Diagn (2014) 1.98
Caveolin-1 null mice develop cardiac hypertrophy with hyperactivation of p42/44 MAP kinase in cardiac fibroblasts. Am J Physiol Cell Physiol (2002) 1.86
The adipocyte as an important target cell for Trypanosoma cruzi infection. J Biol Chem (2005) 1.82
Microsporidiosis: not just in AIDS patients. Curr Opin Infect Dis (2011) 1.77
Genomic survey of the non-cultivatable opportunistic human pathogen, Enterocytozoon bieneusi. PLoS Pathog (2009) 1.73
Post-translational modifications to Toxoplasma gondii alpha- and beta-tubulins include novel C-terminal methylation. J Proteome Res (2010) 1.64
Perspectives on Trypanosoma cruzi-induced heart disease (Chagas disease). Prog Cardiovasc Dis (2009) 1.60
Role of fatty acid binding proteins and long chain fatty acids in modulating nuclear receptors and gene transcription. Lipids (2007) 1.59
Fatal myositis due to the microsporidian Brachiola algerae, a mosquito pathogen. N Engl J Med (2004) 1.51
Mechanisms of Trypanosoma cruzi persistence in Chagas disease. Cell Microbiol (2012) 1.45
Caveolin-1/3 double-knockout mice are viable, but lack both muscle and non-muscle caveolae, and develop a severe cardiomyopathic phenotype. Am J Pathol (2002) 1.43
Type II Toxoplasma gondii KU80 knockout strains enable functional analysis of genes required for cyst development and latent infection. Eukaryot Cell (2011) 1.40
Host cell autophagy is induced by Toxoplasma gondii and contributes to parasite growth. J Biol Chem (2008) 1.34
Chagas disease has now gone global. PLoS Negl Trop Dis (2011) 1.34
Control of Toxoplasma reactivation by rescue of dysfunctional CD8+ T-cell response via PD-1-PDL-1 blockade. Proc Natl Acad Sci U S A (2011) 1.34
Caveolin-1 null (-/-) mice show dramatic reductions in life span. Biochemistry (2003) 1.31
The reduced genome of the parasitic microsporidian Enterocytozoon bieneusi lacks genes for core carbon metabolism. Genome Biol Evol (2010) 1.30
The microsporidian polar tube: a highly specialised invasion organelle. Int J Parasitol (2005) 1.28
Cardioprotective effects of verapamil on myocardial structure and function in a murine model of chronic Trypanosoma cruzi infection (Brazil Strain): an echocardiographic study. Int J Parasitol (2002) 1.27
Current understanding of immunity to Trypanosoma cruzi infection and pathogenesis of Chagas disease. Semin Immunopathol (2012) 1.26
Thromboxane A2 is a key regulator of pathogenesis during Trypanosoma cruzi infection. J Exp Med (2007) 1.21
Microarray analysis of changes in gene expression in a murine model of chronic chagasic cardiomyopathy. Parasitol Res (2003) 1.19
Trypanosoma cruzi utilizes the host low density lipoprotein receptor in invasion. PLoS Negl Trop Dis (2011) 1.17
Induction of a rapid and strong antigen-specific intraepithelial lymphocyte response during oral Encephalitozoon cuniculi infection. J Immunol (2004) 1.17
Parasitic diseases of the heart. Front Biosci (2004) 1.17
Cognitive dysfunction in mice infected with Plasmodium berghei strain ANKA. J Infect Dis (2008) 1.16
Patterns of genome evolution among the microsporidian parasites Encephalitozoon cuniculi, Antonospora locustae and Enterocytozoon bieneusi. PLoS One (2007) 1.16
Antibody efficacy in murine pulmonary Cryptococcus neoformans infection: a role for nitric oxide. J Immunol (2002) 1.16
Genome sequence surveys of Brachiola algerae and Edhazardia aedis reveal microsporidia with low gene densities. BMC Genomics (2008) 1.16
Bone marrow cell therapy ameliorates and reverses chagasic cardiomyopathy in a mouse model. J Infect Dis (2008) 1.16
Role of endothelin 1 in the pathogenesis of chronic chagasic heart disease. Infect Immun (2005) 1.15
Chagas' disease and AIDS. Kinetoplastid Biol Dis (2004) 1.12
Trypanosoma cruzi infection of cultured adipocytes results in an inflammatory phenotype. Obesity (Silver Spring) (2008) 1.12
Toxoplasma: the next 100years. Microbes Infect (2008) 1.12
Toxoplasmosis. Handb Clin Neurol (2013) 1.11
Acquired infection with Toxoplasma gondii in adult mice results in sensorimotor deficits but normal cognitive behavior despite widespread brain pathology. Microbes Infect (2010) 1.09
Response of adipose tissue to early infection with Trypanosoma cruzi (Brazil strain). J Infect Dis (2012) 1.09
Trypanosoma cruzi infection activates extracellular signal-regulated kinase in cultured endothelial and smooth muscle cells. Infect Immun (2004) 1.08
Computational analysis and experimental validation of gene predictions in Toxoplasma gondii. PLoS One (2008) 1.08
Molecular diagnostic tests for microsporidia. Interdiscip Perspect Infect Dis (2009) 1.08
Gain and loss of multiple functionally related, horizontally transferred genes in the reduced genomes of two microsporidian parasites. Proc Natl Acad Sci U S A (2012) 1.08
Activation of transcription factors AP-1 and NF-kappa B in murine Chagasic myocarditis. Infect Immun (2003) 1.07
Endothelin in a murine model of cerebral malaria. Exp Biol Med (Maywood) (2006) 1.06
Liver type fatty acid binding protein (L-FABP) gene ablation reduces nuclear ligand distribution and peroxisome proliferator-activated receptor-alpha activity in cultured primary hepatocytes. Arch Biochem Biophys (2009) 1.05
Glucose directly links to lipid metabolism through high affinity interaction with peroxisome proliferator-activated receptor alpha. J Biol Chem (2007) 1.05
Hepatic phenotype of liver fatty acid binding protein gene-ablated mice. Am J Physiol Gastrointest Liver Physiol (2009) 1.04
Cerebral malaria: we have come a long way. Am J Pathol (2012) 1.04
ApiAP2 transcription factor restricts development of the Toxoplasma tissue cyst. Proc Natl Acad Sci U S A (2013) 1.04
Fluorescence techniques using dehydroergosterol to study cholesterol trafficking. Lipids (2008) 1.03
Identification and characterisation of a regulatory region in the Toxoplasma gondii hsp70 genomic locus. Int J Parasitol (2004) 1.03
Ablation of the liver fatty acid binding protein gene decreases fatty acyl CoA binding capacity and alters fatty acyl CoA pool distribution in mouse liver. Biochemistry (2003) 1.03
Novel synthetic polyamines are effective in the treatment of experimental microsporidiosis, an opportunistic AIDS-associated infection. Antimicrob Agents Chemother (2002) 1.03
Role of mitogen-activated protein kinases in inducible nitric oxide synthase and TNFalpha expression in human fetal astrocytes. J Neuroimmunol (2002) 1.02
Chagas heart disease: report on recent developments. Cardiol Rev (2012) 1.02
IFN-gamma-producing dendritic cells are important for priming of gut intraepithelial lymphocyte response against intracellular parasitic infection. J Immunol (2007) 1.02
Characterization of Mycobacterium montefiorense sp. nov., a novel pathogenic Mycobacterium from moray eels that is related to Mycobacterium triplex. J Clin Microbiol (2003) 1.01
Comprehensive proteomic analysis of membrane proteins in Toxoplasma gondii. Mol Cell Proteomics (2010) 1.00
Microarray technology in the investigation of diseases of myocardium with special reference to infection. Front Biosci (2006) 1.00
Persistent cognitive and motor deficits after successful antimalarial treatment in murine cerebral malaria. Microbes Infect (2010) 1.00
Cardioprotective effects of phosphoramidon on myocardial structure and function in murine Chagas' disease. Int J Parasitol (2002) 0.99
Cerebral malaria: a vasculopathy. Am J Pathol (2010) 0.99
Glucose regulates fatty acid binding protein interaction with lipids and peroxisome proliferator-activated receptor α. J Lipid Res (2010) 0.99
Cyclic nucleotide kinases and tachyzoite-bradyzoite transition in Toxoplasma gondii. Int J Parasitol (2005) 0.99
Identification of a new spore wall protein from Encephalitozoon cuniculi. Infect Immun (2006) 0.98
Crucial role of the central leptin receptor in murine Trypanosoma cruzi (Brazil strain) infection. J Infect Dis (2010) 0.98
Significance of inducible nitric oxide synthase in acute myocarditis caused by Trypanosoma cruzi (Tulahuen strain). Int J Parasitol (2002) 0.98
Liver fatty acid binding protein expression enhances branched-chain fatty acid metabolism. Mol Cell Biochem (2004) 0.97
Alterations in myocardial gene expression associated with experimental Trypanosoma cruzi infection. Genomics (2008) 0.97
Aspirin treatment of mice infected with Trypanosoma cruzi and implications for the pathogenesis of Chagas disease. PLoS One (2011) 0.97
EPIC-DB: a proteomics database for studying Apicomplexan organisms. BMC Genomics (2009) 0.96
Role of SOCS2 in modulating heart damage and function in a murine model of acute Chagas disease. Am J Pathol (2012) 0.96
Mitochondrial-type hsp70 genes of the amitochondriate protists, Giardia intestinalis, Entamoeba histolytica and two microsporidians. Parasitol Int (2002) 0.95
Cyclin and caveolin expression in an acute model of murine Chagasic myocarditis. Cell Cycle (2006) 0.95
Glycosylation of the major polar tube protein of Encephalitozoon hellem, a microsporidian parasite that infects humans. Infect Immun (2004) 0.95
Effects of early and late verapamil administration on the development of cardiomyopathy in experimental chronic Trypanosoma cruzi (Brazil strain) infection. Parasitol Res (2004) 0.94
Trypanosoma cruzi induces changes in cardiac connexin43 expression. Microbes Infect (2007) 0.94
A review of the development of two types of human skeletal muscle infections from microsporidia associated with pathology in invertebrates and cold-blooded vertebrates. Folia Parasitol (Praha) (2005) 0.94
3-Methyladenine blocks Toxoplasma gondii division prior to centrosome replication. Mol Biochem Parasitol (2010) 0.94
Acquisition of an animal gene by microsporidian intracellular parasites. Curr Biol (2011) 0.94
Investigations into microsporidian methionine aminopeptidase type 2: a therapeutic target for microsporidiosis. Folia Parasitol (Praha) (2005) 0.94
[Hemolytic disease of neonates due to anti-M: report of one case and review of reports of 21 cases]. Zhonghua Er Ke Za Zhi (2009) 0.94
Trypanosoma cruzi infection induces proliferation of vascular smooth muscle cells. Infect Immun (2006) 0.94
Microarray analysis of IFN-gamma response genes in astrocytes. J Neuroimmunol (2006) 0.93
Curcumin treatment provides protection against Trypanosoma cruzi infection. Parasitol Res (2012) 0.93